© 2004 by European Society of Cardiology
Copyright © 2004, European Society of Cardiology
Angiotensin AT2 receptor: the younger sibling attracts attention
Department of Preclinical and Clinical Pharmacology, University of Firenze, Viale Pieraccini 6, Florence 50139, Italy
* Corresponding author. Tel.: +39-554271264; fax: +39-554271285. Email address: alessandro.mugelli@unifi.it
Received 26 January 2004; accepted 29 January 2004
| The first 10% of the full text of this article appears below. |
See article by Caballero et al. [6] (pages 86–95) in this issue.
Electrical remodeling is a crucial aspect of the general process of cardiac remodeling associated with left ventricular hypertrophy and heart failure [1], and it is thought to contribute to an increased risk of ventricular fibrillation and sudden cardiac death. Angiotensin II has long been recognized as a major factor in cardiac remodeling in a variety of cardiovascular and non-cardiovascular diseases—from hypertension to diabetes [2]. Two receptor subtypes for angiotensin II have been identified in the heart, AT1 and AT2, which apparently share two features: the endogenous ligand and the gross molecular structure, belonging
| 1. Angiotensin receptors and electrophysiological remodeling |
|---|
| 2. Physiological and clinical implications and open questions |
|---|
This article has been cited by other articles:
![]() |
G. W. Booz Cardiac Angiotensin AT2 Receptor: What Exactly Does It Do? Hypertension, June 1, 2004; 43(6): 1162 - 1163. [Full Text] [PDF] |
||||
